Recombinant Cells as a Tool for Evaluating the Specific Activity of Radiolabeled Antibodies against Endoglin (CD105)-Reference-Cited by-同舟云学术

Recombinant Cells as a Tool for Evaluating the Specific Activity of Radiolabeled Antibodies against Endoglin (CD105)

Published:2023-12 Issue:7 Volume:59 Page:1018-1026
ISSN:0003-6838
Container-title:Applied Biochemistry and Microbiology
language:en
Short-container-title:Appl Biochem Microbiol

Author:

Shashkova O. A.,Smirnov I. V.,Pinevich A. A.,Avrov K. O.,Terekhina L. A.,Malakhov I. S.,Stolbovaya A. Yu.,Gryazeva I. V.,Vartanyan N. L.,Krutetskaya I. Yu.,Antuganov D. O.,Shatik S. V.,Samoilovich M. P.

Publisher

Pleiades Publishing Ltd

Subject

Applied Microbiology and Biotechnology,Biochemistry

Link

https://link.springer.com/content/pdf/10.1134/S0003683823070049.pdf

Reference24 articles.

1. Garousi, J., Orlova, A., Frejd, F.Y., and Tolmachev, V., Imaging using radiolabelled targeted proteins: radioimmunodetection and beyond, EJNMMI Radiopharm. Chem., 2020, vol. 5, no. 1, p. 16. https://doi.org/10.1186/s41181-020-00094-w

2. Wadas, T.J., Wong, E.H., Weisman, G.R., and Anderson, C.J., Coordinating radiometals of copper, gallium, indium, yttrium and zirconium for PET and SPECT imaging of disease, Chem. Rev., 2010, vol. 110, no. 5, pp. 2858–2902. https://doi.org/10.1021/cr900325h

3. Vivier, D., Sharma, S.K., and Zegluis, B.M., Understanding the in vivo fate of radioimmunoconjugates for nuclear imaging, J. Labelled Comp. Radiopharm., 2018, vol. 61, no. 9, pp. 672–692. https://doi.org/10.1002/jlcr.3628

4. Carter, L.M., Poty, S., Sharma, S.K., and Lewis, J.S., Preclinical optimization of antibody-based radiopharmaceuticals for cancer imaging and radionuclide therapy—model, vector, and radionuclide selection, J. Labelled Comp. Radiopharm., 2018, vol. 61, no. 9, pp. 611–635. https://doi.org/10.1002/jlcr.3612

5. Klimovich, V.B., Pinevich, A.A., Smirnov, I.V., et al., Perspectives of application of antibodies against endoglin (CD105) for visualization and anti-angiogene therapy of tumors, Vopr. Onkol., 2018, vol. 64, no. 4, pp. 504–507. https://doi.org/10.37469/0507-3758-2018-64-4-504-507